Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Rebalancing can affect how withdrawal rates hold up over time. Learn factors that influence stability and how to adjust portfolio rules.
24,481 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Worthington Steel stock dropped today after the company reported solid revenue growth but weak earnings due to higher...
A federal lawsuit claims Meta’s Ray-Ban AI glasses expose user footage to human reviewers overseas, challenging the c...
Bitcoin surged to a three-month high, topping the $82,000 mark amid fresh geopolitical chatter and improving market s...
IREN leaps on a landmark NVIDIA AI Cloud contract and a parallel equity option, signaling a strategic pivot from cryp...
Curious about a nuclear-tech stock with big growth potential? This guide breaks down the case for buying oklo stock t...
Intel’s stock falling guiding the chip sector into a rough day as inflation data raises concerns about data-center sp...
Poly Truth is rolling out an AI-powered intelligence layer for prediction markets, promising data-driven insights on ...
Biotech earnings chants are rarely about profits for small developers. This guide explains how to read Celcuity's 202...
SpaceX is charging toward a historic IPO, aiming for a mid-June pricing and a Nasdaq debut under SPCX. The deal could...
Ethereum traded near a three-month low as risk-off conditions weighed on prices. Analysts flagged ethereum (eth) indi...
Super Micro Computer led AI infra shares higher today as demand for AI servers strengthens. The move contrasts with m...